Welcome to LookChem.com Sign In|Join Free

CAS

  • or

59245-36-2

Post Buying Request

59245-36-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59245-36-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 59245-36-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,2,4 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 59245-36:
(7*5)+(6*9)+(5*2)+(4*4)+(3*5)+(2*3)+(1*6)=142
142 % 10 = 2
So 59245-36-2 is a valid CAS Registry Number.

59245-36-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-deoxy-L-arabinose phenylhydrazone

1.2 Other means of identification

Product number -
Other names 5-deoxy-L-arabinose-phenylhydrazone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59245-36-2 SDS

59245-36-2Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISEASES

-

Paragraph 0168; 0177; 0178, (2015/11/18)

The invention relates to the compounds of formula I, formula II and formula III or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II or formula III; and methods for treating or preventing metabolic diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of phenylketonuria, cardiovascular disease, autism, ADHD, hypertension, endothelial dysfunction and chronic kidney disease.

Method for producing L-biopterin

-

Page/Page column 5, (2008/06/13)

To provide a method for producing L-biopterin on a large industrial scale by using a reagent which is inexpensive and easy to handle, without requiring a use of any particular equipment or plants.

169. Pterinechemistry Part 84 A New, Regiospecific Synthesis of L-Biopterin

Schircks, Bernhard,Bieri, Jost H.,Viscontini, Max

, p. 1639 - 1643 (2007/10/02)

Pure L-biopterin was obtained in 42percent yield by the condensation of 5-deoxy-L-arabinose-phenylhydrazone-triacetate with 4-hydroxy-2,5,6-triaminopyrimidine, followed by iodine oxidation of the formed tetrahydropterin derivative to 1',2'-O-diacetyl-L-biopterin.Deacetylation was carried out with NH4OH.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 59245-36-2